The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Blood-borne assessment of stromal activation in esophageal adenocarcinoma to guide tocilizumab therapy: A randomized phase II proof-of-concept study (NCT04554771).
 
Benthe Doeve
No Relationships to Disclose
 
Roos E. Pouw
No Relationships to Disclose
 
Mark I. Van Berge Henegouwen
Consulting or Advisory Role - Alesi Surgical (Inst); Braun Travacare (Inst); Johnson & Johnson (Inst); Medtronic (Inst); Mylan (Inst)
Research Funding - Olympus (Inst); Stryker (Inst)
Travel, Accommodations, Expenses - Johnson & Johnson
 
Maarten C.C.M. Hulshof
No Relationships to Disclose
 
Jan Paul Medema
No Relationships to Disclose
 
Sarah Derks
No Relationships to Disclose
 
Maarten F. Bijlsma
No Relationships to Disclose
 
Hanneke W.M. Van Laarhoven
Consulting or Advisory Role - Bristol-Myers Squibb; Dragonfly Therapeutics; Merck; Servier
Research Funding - Bayer Schering Pharma (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Incyte (Inst); Janssen-Cilag (Inst); Lilly (Inst); Merck KGaA (Inst); Merck Sharp & Dohme (Inst); Nordic Group (Inst); Philips Healthcare (Inst); Roche (Inst); Servier (Inst)
Travel, Accommodations, Expenses - AstraZeneca